Chinese and foreign giants: The biological medicine industry " The midwest combines harmoniously " It is the trend of the times

Chinese and foreign giants: The biological medicine industry " The midwest combines harmoniously " It is the trend of the times
Cable of June 26 of www.chinanews.com Suzhou (brave refined Zhou Xin Liao) The international cooperation forum that China's biological medicine field is of the largest scale lowered the curtain in Suzhou a few days ago, but to Chinese and foreign medical giants participating in the conference " Cooperation " But just raised the curtain. As soon as the forum is over, pharmacy giant begin to canvass their " hope list " . " fight rapidly " It is the best method Bayer efficacious medicine is a global famous medical trans-corporation first, also generally acknowledged in successful enterprise most one of, localization of China, occupy important share in the intersection of Chinese and diabetes, the intersection of cardiovascular vessel and the intersection of disease and the intersection of administration,etc. and field not merely. Nowadays, China's biological medicine has fast growing industry, in the face of the domestic and huge market of health, Bayer is efficacious first to accelerate the development in China too. In the face of reporter, Bayer clever the intersection of medicine and global medicine explore the intersection of China and innovative Ma Xin Dr., director of centre, and speak she participate in this time forum to come, look for cooperative partner with concealing anything first. At the beginning of this year, the efficacious China district seperates from original the Asian-Pacific area first Bayer, upgrade to a district reported to the general headquarters directly, before this, ripe markets such as Europe and U.S.A. report to the general headquarters directly. This show the intersection of Bayer and clever attention in Chinese market first fully, prove Bayer to be first clever next the Chinese market of the overall arrangement at faster speed too. And this Suzhou trip, Dr. of Xin, Ma, the intersection of Bayer and clever new a simple epitome of tactics first too. Ma Xin says, the demand of the medical consumer market of China and pace of change are surprising, the competitiveness of the native rival is being developed constantly, the international medical giant does not still reduce in China's growth momentum at the same time, the whole trade is piecing together products, channel and flexibility too. Ma Xin says, one of Bayer's first efficacious countermeasures is according to the new products of China's native medical market development with stronger adaptive capacity, and it is one of the method routes to seek cooperation. " united by marriage " It is the trend of the times that, in and and the reporter's exchange, the intersection of Britain and medical Slay of giant A the intersection of health and right away will say hello with acquaintancing frequently, Dr. of LiQun, Wang, director of strategic cooperation. Wang LiQun Dr. say, participate in a lot of forums or meetings in domestic him, but can picture touch so many familiar face like this this time, make him in a unexpected one even more seldom, a lot of big companies on the senior level have all come, has reflected " this forum is unusual " from the side . As a reputable professional in the industry, Dr. Wang LiQun knows global current situation of the development and trend of biological medicine industry well. And got the new medicine through the research and development and technological cooperation between the companies or organizations, have already become the medical trade development trend now. As to this, Dr. Wang LiQun says, this kind of trend is in the whole world the medical market manifestation is very obvious, and is strengthening constantly, the same in China. In the past 20 years, nearly all new and listing medicines " cooperate " through all kinds of Born, all large-scale drugmakers had set up technology and cooperative department too. China is becoming the centre that is being studied development of global pharmacy at full speed, and is attracting the leading medicine of world and company of the biotechnology. These companies are looking for a large number of cooperative chances, in order to combine China's sturdy theoretical research, resources such as outstanding scientific research personnel and low-cost transporation,etc.. So, the cooperative trade has already become a great important component of the fast and developing Chinese biological medicine industry. The statistics show, the quantity of the cooperative trade rise by 41% in 2009, among them increase the fastest part and develop the trade cooperatively. Facilitate its factor increased fast to include more than 2000 new compounds that China researches and develops independently, among them nearly 200 have already been at researching and developing stage clinically. " occidentalize " But can't forget one " the medical enterprises of China can't imitate the foreign tactics to research and develop competence to promote oneself new medicine, traditional Chinese medicine is the soul of Chinese medicine all the time, can not lose. " It is while promoting new medicine to research and develop competence and discuss warmly how is it in one slice as the personnel present, the view that founder, president from famous medical advisory company Kinesis of Holland Hu Ke puts forward provides food for thought. Kinesis is a famous medical advisory company of Holland. Since 1997, with the intersection of Europe and every large the intersection of medicine company and Company and the experiment and close cooperation of research and development department of clinical trial in front of the clinic of biotech company, offer medicines to them to research and develop and consult and test and serve, aim at helping them to set up a piece of fast and high-efficient medicines and research and develop the course. In recent years, their market expands from Europe to China. As to the fast growing Chinese market, Hu Ke has a good prospect very much, he thinks the stage when new medicine has researched and developed that the Chinese market has already developed from producing imitation medicine to at present, the large quantities of new developing biological medicine enterprises with research and development ability of new medicine have emerged out, and the government here encourages very much, possess positive facilitation in promoting the Chinese market. But develop the current situation of new medicine of Western medicine to the enterprises at present in a large amount, Hu Ke demonstrates one's own worry, he says, China can duplicate foreign direction and tactics briefly in the energetical development biological medicine industry, can not lose traditional Chinese medicine, traditional Chinese medicine combines with Western medicine and can let China show unique characteristics in the medical trade, have one's own advantages. It is introduced, at present, already traditional Chinese medicine register on the European market. And because of some advantages of traditional Chinese medicine, increasingly many Europeans begin to accept traditional Chinese medicine gradually in recent years. (End)

|